My Quote Request
No products added yet
6505-01-202-8882
20 Products
NDC00469-3400-00
GLYCOPYRROLATE INJECTION,USP
NSN, MFG P/N
6505012028882
NSN
6505-01-202-8882
NDC00469-3400-00
GLYCOPYRROLATE INJECTION,USP
NSN, MFG P/N
6505012028882
NSN
6505-01-202-8882
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS GLYCOPYRROLATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS OR INTRAMUSCULAR
III SUPPLEMENTARY FEATURES: 2 ML PARTIAL FILL VIAL
PHARMACEUTICAL VEHICLE TYPE: HYDROALCOHOLIC
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: FLIPTOP SINGLE DOSE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00052-0442-17
VECURONIUM BROMIDE FOR INJECTION
NSN, MFG P/N
6505012022230
NSN
6505-01-202-2230
NDC00052-0442-17
VECURONIUM BROMIDE FOR INJECTION
NSN, MFG P/N
6505012022230
NSN
6505-01-202-2230
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS VECURONIUM BROMIDE ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 MG. VECURONIUM BROMIDE PER ML; PROVIDES 5 ML. OF SOLUTION AFTER RECONSTITUTION; WITH TEN 5 ML VIALS OF BACTERIOSTATIC WATER FOR INJECTION,USP AS DILUENT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NORCURON
VECURONIUM BROMIDE FOR INJECTION
NSN, MFG P/N
6505012022230
NSN
6505-01-202-2230
NORCURON
VECURONIUM BROMIDE FOR INJECTION
NSN, MFG P/N
6505012022230
NSN
6505-01-202-2230
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS VECURONIUM BROMIDE ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 MG. VECURONIUM BROMIDE PER ML; PROVIDES 5 ML. OF SOLUTION AFTER RECONSTITUTION; WITH TEN 5 ML VIALS OF BACTERIOSTATIC WATER FOR INJECTION,USP AS DILUENT
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
AMICAR
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMINOCAPROIC ACID PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINOCAPROIC ACID SYRUP USP 250MG/ML 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
AMICAR SYRUP
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
AMICAR SYRUP
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMINOCAPROIC ACID PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINOCAPROIC ACID SYRUP USP 250MG/ML 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00005-4667-65
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
NDC00005-4667-65
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMINOCAPROIC ACID PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINOCAPROIC ACID SYRUP USP 250MG/ML 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC58406-0611-90
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
NDC58406-0611-90
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMINOCAPROIC ACID PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINOCAPROIC ACID SYRUP USP 250MG/ML 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC61748-0044-16
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
NDC61748-0044-16
AMINOCAPROIC ACID SYRUP,USP
NSN, MFG P/N
6505012022232
NSN
6505-01-202-2232
MFG
VERSAPHARM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS AMINOCAPROIC ACID PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMINOCAPROIC ACID SYRUP USP 250MG/ML 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
14-4373
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012025346
NSN
6505-01-202-5346
14-4373
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012025346
NSN
6505-01-202-5346
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 GRAMS CALCIUM CARBONATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM CARBONATE TABLETS USP 500MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 500 MG ELEMENTAL CALCIUM PER TABLET; NON CHEWABLE
Related Searches:
NDC00182-1576-10
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012025346
NSN
6505-01-202-5346
NDC00182-1576-10
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012025346
NSN
6505-01-202-5346
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 GRAMS CALCIUM CARBONATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM CARBONATE TABLETS USP 500MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 500 MG ELEMENTAL CALCIUM PER TABLET; NON CHEWABLE
Related Searches:
OYST-CAL 500
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012025346
NSN
6505-01-202-5346
OYST-CAL 500
CALCIUM CARBONATE TABLETS,USP
NSN, MFG P/N
6505012025346
NSN
6505-01-202-5346
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 GRAMS CALCIUM CARBONATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CALCIUM CARBONATE TABLETS USP 500MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 500 MG ELEMENTAL CALCIUM PER TABLET; NON CHEWABLE
Related Searches:
NDC00469-1390-60
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012027997
NSN
6505-01-202-7997
NDC00469-1390-60
SODIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012027997
NSN
6505-01-202-7997
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 14.600 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS INFUSION
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: FLIPTOP VIAL,SINGLE DOSE
SPECIAL FEATURES: WITHOUT PRESERVATIVES
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
76-20
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
76-20
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 20ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
I-093
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
I-093
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 20ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00469-7600-40
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
NDC00469-7600-40
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 20ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00517-2053-25
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
NDC00517-2053-25
POTASSIUM ACETATE INJECTION,USP
NSN, MFG P/N
6505012027998
NSN
6505-01-202-7998
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS POTASSIUM ACETATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POTASSIUM ACETATE INJECTION USP 20ML VIAL 25S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00026-3095-55
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012028086
NSN
6505-01-202-8086
NDC00026-3095-55
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012028086
NSN
6505-01-202-8086
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CLOTRIMAZOLE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE TROCHES 10MG 70 TROCHES BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 70.000 TROCHES
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
Related Searches:
NDC00054-4146-22
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012028086
NSN
6505-01-202-8086
NDC00054-4146-22
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012028086
NSN
6505-01-202-8086
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CLOTRIMAZOLE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE TROCHES 10MG 70 TROCHES BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 70.000 TROCHES
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
Related Searches:
NDC17314-9400-01
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012028086
NSN
6505-01-202-8086
NDC17314-9400-01
CLOTRIMAZOLE TROCHES
NSN, MFG P/N
6505012028086
NSN
6505-01-202-8086
MFG
ALZA CORP ALZA PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CLOTRIMAZOLE ACTIVE INGREDIENT
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE TROCHES 10MG 70 TROCHES BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 70.000 TROCHES
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
Related Searches:
NDC00469-6400-10
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505012028881
NSN
6505-01-202-8881
NDC00469-6400-10
MAGNESIUM SULFATE INJECTION,USP
NSN, MFG P/N
6505012028881
NSN
6505-01-202-8881
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V MAGNESIUM SULFATE PER MILLILITER
ADMINISTRATION: INTRAVENOUS INFUSION
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: FLIPTOP VIAL,SINGLE DOSE
SPECIAL FEATURES: 5 ML PARTIAL FILL OVERSIZE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 25
